WOK
WORK Medical Technology Group Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · CN
$2.10
+1.45%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 21.5M | 9.8M | 11.5M | 13.6M | 19.7M |
| Cost of Revenue | 17.3M | 7.5M | 8.6M | 9.4M | 15.3M |
| Gross Profit | 4.2M | 2.3M | 2.9M | 4.1M | 4.4M |
| Operating Expenses | |||||
| R&D Expense | 657.7K | 435.3K | 302.5K | 301.6K | 183.9K |
| SG&A Expense | 13.1M | 4.4M | 6.6M | 3.4M | 3.6M |
| General & Admin Expense | 6.1M | 2.3M | 4.6M | 1.9M | 2.6M |
| Selling & Marketing Expense | 3.0M | 2.1M | 2.1M | 1.6M | 1.0M |
| Other Expenses | — | — | (346.6K) | (74.2K) | (1.2M) |
| Total Operating Expenses | 13.8M | 4.8M | 6.6M | 3.7M | 2.6M |
| Cost and Expenses | 31.0M | 12.3M | 15.2M | 13.1M | 17.9M |
| Operating Income (EBIT) | (9.6M) | (2.5M) | (3.7M) | 486.5K | 1.8M |
| Non-Operating | |||||
| Interest Income | 217.4K | 181.7K | 11.7K | — | — |
| Interest Expense | 914.8K | 503.5K | 557.6K | 367.3K | 351.0K |
| Net Interest Income | (697.3K) | (321.8K) | (545.8K) | (367.3K) | (351.0K) |
| Other Non-Op Income/Expense | 1.4M | 1.4M | 379.5K | (376.1K) | 475.2K |
| Non-Operating Income (excl Interest) | (185.6K) | (1.9M) | (590.5K) | 8.7K | 360.4K |
| EBT (Pre-Tax Income) | (8.3M) | (1.1M) | (3.7M) | 110.4K | 1.1M |
| Income Tax Expense | 172.5K | 119.1K | (125.3K) | 47.0K | 169.4K |
| Bottom Line | |||||
| Net Income | (8.2M) | (1.1M) | (3.5M) | 112.0K | 865.2K |
| Earnings from Cont. Ops | (8.5M) | (1.2M) | (3.5M) | 63.4K | 944.1K |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (8.2M) | (1.1M) | (3.5M) | 112.0K | 865.2K |
| Per Share | |||||
| Basic EPS | ($237.15) | ($37.01) | ($27.00) | $0.90 | $6.92 |
| Diluted EPS | ($237.15) | ($37.01) | ($27.00) | $0.90 | $6.92 |
| Revenue Per Share | $1,244.28 | $33.98 | $90.57 | $108.53 | $157.69 |
| Shares | |||||
| Basic Shares Outstanding | 17246 | 289800 | 127050 | 125000 | 125000 |
| Diluted Shares Outstanding | 17246 | 289800 | 127050 | 125000 | 125000 |
| Profitability Metrics | |||||
| EBITDA | (7.3M) | 339.4K | (1.7M) | 2.1M | 4.7M |
| D&A | 2.1M | 917.8K | 1.4M | 1.6M | 3.3M |
| EBIT | (9.4M) | (578.5K) | (3.1M) | 477.7K | 1.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026